Norges Bank Catalyst Pharmaceuticals, Inc. Transaction History

Norges Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$11.69 - $15.02 $10.4 Million - $13.4 Million	-891,800 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $3.85 Million - $6.13 Million	314,400 New	314,400 $5.85 Million
Q3 2022 Nov 13, 2023	BUY	$7.06 - $15.52 $6.3 Million - $13.8 Million	891,800 New	891,800 $11.4 Million

326

94M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.19B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.